Showing results (1621-1630 of 1,756) with videos related to

Sort By:
Pageof 176
Scientific Reports|April 16, 2026
Machine learning-based risk stratification identifies heart failure with preserved ejection fraction as an independent predictor of adverse outcomes in hypertrophic cardiomyopathyWeijie Zhang, Huan Zhao, Zhuchang Tian, et al.
Communications Biology|November 14, 2022
Anti-tumor effects of P-LPK-CPT, a peptide-camptothecin conjugate, in colorectal cancerLidan Hou, Yichao Hou, Yu Liang, et al.
Applied Optics|August 12, 2025
Visible light blocking performance of a wide-field X-ray telescope onboard the Einstein probeYifan Chen, Zhengda Li, Xiaojin Sun, et al.
Frontiers in Cellular and Infection Microbiology|June 29, 2026
<i>In vitro</i> interspecies interactions between methicillin-resistant <i>Staphylococcus aureus</i> and <i>Pseudomonas aeruginosa</i>: effects on bacterial growth, antibiotic susceptibility, and transcriptomic reprogrammingXinliang Peng, Hang Zhou, Wanchang Liu, et al.
Bioorganic & Medicinal Chemistry|September 4, 2025
Design, synthesis, and biological activity of novel para-substituted phenylamino and phenyl derivatives of northebaine as selective delta opioid receptor agonistsDenggao Zhang, Jiangwen Gui, Linghui Kong, et al.
The Journal of Biological Chemistry|March 27, 2009
MDM2 acts downstream of p53 as an E3 ligase to promote FOXO ubiquitination and degradationWei Fu, Qiuping Ma, Lei Chen, et al.
Nature Communications|January 14, 2018
Carbon-doped SnS<sub>2</sub> nanostructure as a high-efficiency solar fuel catalyst under visible lightIndrajit Shown, Satyanarayana Samireddi, Yu-Chung Chang, et al.
Frontiers in Oncology|October 16, 2019
Radiomics Facilitates Candidate Selection for Irradiation Stents Among Patients With Unresectable Pancreatic CancerHai-Feng Zhou, Yu-Qi Han, Jian Lu, et al.
Journal of Medicinal Chemistry|February 22, 2023
Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor AgonistsBin Shan, Hui Hou, Keke Zhang, et al.
Vaccines|January 28, 2026
Randomized Phase 3 Trial Evaluating the Safety, Tolerability, and Immunogenicity of V114, a 15-Valent PCV, Followed by PPSV23 6 Months Later (PNEU-DAY): Subgroup Analysis in Adults 18-49 Years of Age Enrolled at Center for Indigenous Health SitesLaura L Hammitt, Ulrike K Buchwald, Jennifer McCauley, et al.
Pageof 176